Brief: Intensity Therapeutics Says Pursuant To Collaboration Deal, Co To Supply SAKK With INT230-6 As Well As Funding In Amount Of Up To About $3 Mln
10/05/2024 21:35
May 10 (Reuters) - Intensity Therapeutics Inc INTS.O :
* INTENSITY THERAPEUTICS-PURSUANT TO COLLABORATION DEAL, CO
TO
SUPPLY SAKK WITH INT230-6 AS WELL AS FUNDING IN AMOUNT OF UP TO
ABOUT $3.0 MILLION
Source text for Eikon: ID:n0001567264-24-000013
Further company coverage: INTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intensity Therapeutics
See all newsIntensity Therapeutics Q2 net loss widens as R&D costs rise
Brief: Intensity Therapeutics Q2 Operating Income USD -3.084 Million
Intensity Therapeutics Q1 net loss narrows on lower R&D costs
Brief: Intensity Therapeutics Q1 Operating Income USD -2.526 Million
Brief: Intensity Therapeutics Inc - Increases ATM Offering Capacity To $60 Million On March 23, 2026 - SEC Filing